The SF-6Dv2: How Does the New Classification System Impact the Distribution of Responses Compared with the Original SF-6D?

Whitehurst, DGT Brazier, JE Viney, R

Mulhern, BJ

Permalink

Closed Access

	Filename	Description	Size
	RV & BM_SF-6Dv2.pdf		827.64 kB	Adobe PDF	View/Open

Copyright Clearance Process

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	Whitehurst, DGT
dc.contributor.author	Brazier, JE
dc.contributor.author	Viney, R https://orcid.org/0000-0002-0039-9635
dc.contributor.author	Mulhern, BJ
dc.date.accessioned	2021-02-04T23:38:22Z
dc.date.available	2021-02-04T23:38:22Z
dc.date.issued	2020-12
dc.identifier.citation	PharmacoEconomics, 2020, 38, (12), pp. 1283-1288
dc.identifier.issn	1170-7690
dc.identifier.issn	1179-2027
dc.identifier.uri	http://hdl.handle.net/10453/145855
dc.format	Print
dc.language	eng
dc.publisher	ADIS INT LTD
dc.relation.ispartof	PharmacoEconomics
dc.relation.isbasedon	10.1007/s40273-020-00957-9
dc.rights	info:eu-repo/semantics/restrictedAccess
dc.subject	11 Medical and Health Sciences, 14 Economics
dc.subject.classification	Health Policy & Services
dc.title	The SF-6Dv2: How Does the New Classification System Impact the Distribution of Responses Compared with the Original SF-6D?
dc.type	Journal Article
utslib.citation.volume	38
utslib.location.activity	New Zealand
utslib.for	11 Medical and Health Sciences
utslib.for	14 Economics
pubs.organisational-group	/University of Technology Sydney/Faculty of Business
pubs.organisational-group	/University of Technology Sydney/Strength - CHERE - Centre for Health Economics Research and Evaluation
pubs.organisational-group	/University of Technology Sydney
utslib.copyright.status	closed_access	*
dc.date.updated	2021-02-04T23:38:02Z
pubs.issue	12
pubs.publication-status	Published
pubs.volume	38
utslib.citation.issue	12

Please use this identifier to cite or link to this item: